Register now!

The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Promotion of in silico medicine in Horizon 2020;
  • Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
  • Creating links between the VPH Membership and Avicenna Industry Members
  • Priorities in 2016

→ Contribute to the Avicenna Alliance Policy Recommendations on in silico medicine to be submitted to the European Commission;
→ Develop draft suggested Call Texts for proposals for the “Health, Demographic Change and Well-being” sections for Horizon 2020;

Avicenna Alliance news

Avicenna Alliance’s Secretary General to give keynote speech at ICCAI 2017

On 27-29 July 2017, the Society for Complex Acute Illness (SCAI) will organise the 16th annual International Conference on...

find out more ›

Avicenna Alliance represented at eHealth week in Malta!

The Avicenna Alliance has been invited to participate in a session dedicated to in silico trials on 12 May 2017 during the eHealth week in...

find out more ›

Avicenna Alliance invited to Joint Research Centre (JRC) Round Table Meeting in Ispra

The Joint Research Centre (JRC) located in Ispra, Italy organised a Round table meeting on 7 March 2017 to...

find out more ›

Show all activites